Jaloun Heba Essam, Lee In Kyu, Kim Min Ki, Sung Na Young, Turkistani Suhail Abdullah Al, Park Sun Min, Won Dae Youn, Hong Sang Hyun, Kye Bong-Hyeon, Lee Yoon Suk, Jeon Hae Myung
Division of Colorectal Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Cancer Information & Education Branch, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Ann Coloproctol. 2020 Aug;36(4):264-272. doi: 10.3393/ac.2020.03.25. Epub 2020 May 15.
Many studies have shown that the enhanced recovery after surgery (ERAS) protocols improve postoperative surgical outcomes. The purpose of this study was to observe the effects on postoperative inflammatory markers and to explore the effects of a high degree of compliance and the use of epidural anesthesia on inflammation and surgical outcomes.
Four hundred patients underwent colorectal cancer surgery at 2 hospitals during 2 different periods, namely, from January 2006 to December 2009 and from January 2017 to July 2017. Data related to the patient's clinicopathological features, inflammatory markers, percentage of compliance with elements of the ERAS protocol, and use of epidural anesthesia were collected from a prospectively maintained database.
The complication rate and the length of hospital stay (LOS) were less in the ERAS group than in the conventional group (P = 0.005 and P ≤ 0.001, respectively). The postoperative white blood cell count and the duration required for leukocytes to normalize were reduced in patients following the ERAS protocol (P ≤ 0.001). Other inflammatory markers, such as lymphocyte count (P = 0.008), neutrophil/lymphocyte ratio (P = 0.032), and C-reactive protein level (P ≤ 0.001), were lower in the ERAS protocol group. High compliance ( ≥ 70%) was strongly associated with the complication rate and the LOS (P = 0.008 and P ≤ 0.001, respectively).
ERAS protocols decrease early postoperative inflammation and improves short-term postoperative recovery outcomes such as complication rate and the LOS. High compliance ( ≥ 70%) with the ERAS protocol elements accelerates the positive effects of ERAS on surgical outcomes; however, the effect on inflammation was very small.
许多研究表明,术后加速康复(ERAS)方案可改善术后手术结局。本研究的目的是观察其对术后炎症标志物的影响,并探讨高度依从性以及硬膜外麻醉的使用对炎症和手术结局的影响。
400例患者于2个不同时期在2家医院接受了结肠癌手术,即2006年1月至2009年12月以及2017年1月至2017年7月。从一个前瞻性维护的数据库中收集了与患者临床病理特征、炎症标志物、ERAS方案各要素的依从率以及硬膜外麻醉使用情况相关的数据。
ERAS组的并发症发生率和住院时间(LOS)均低于传统组(分别为P = 0.005和P≤0.001)。遵循ERAS方案的患者术后白细胞计数及白细胞恢复正常所需时间缩短(P≤0.001)。ERAS方案组的其他炎症标志物,如淋巴细胞计数(P = 0.008)、中性粒细胞/淋巴细胞比值(P = 0.032)和C反应蛋白水平(P≤0.001)较低。高依从性(≥70%)与并发症发生率和住院时间密切相关(分别为P = 0.008和P≤0.001)。
ERAS方案可减轻术后早期炎症,并改善术后短期恢复结局,如并发症发生率和住院时间。对ERAS方案各要素的高依从性(≥70%)可加速ERAS对手术结局的积极影响;然而,对炎症的影响非常小。